Stock Scorecard
Stock Summary for Dexcom Inc (DXCM) - $74.88 as of 11/20/2024 3:59:03 PM EST
Total Score
11 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DXCM
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DXCM
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DXCM
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DXCM
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for DXCM (50 out of 90)
Stock Price Rating (Max of 10) | 9 |
Historical Stock Price Rating (Max of 10) | 9 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 4 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 5 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 4 |
Trading Volume (Max of 10) | 10 |
Price to Earnings (Max of 10) | 2 |
Latest News for for DXCM
Financial Details for DXCM
Company Overview |
|
---|---|
Ticker | DXCM |
Company Name | Dexcom Inc |
Country | USA |
Description | DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 2/6/2025 |
Stock Price History |
|
Last Day Price | 74.88 |
Price 4 Years Ago | 92.43 |
Last Day Price Updated | 11/20/2024 3:59:03 PM EST |
Last Day Volume | 3,074,861 |
Average Daily Volume | 4,679,141 |
52-Week High | 142.00 |
52-Week Low | 62.34 |
Last Price to 52 Week Low | 20.12% |
Valuation Measures |
|
Trailing PE | 45.60 |
Industry PE | 52.46 |
Sector PE | 40.32 |
5-Year Average PE | 107.34 |
Free Cash Flow Ratio | 12.89 |
Industry Free Cash Flow Ratio | 35.05 |
Sector Free Cash Flow Ratio | 27.97 |
Current Ratio Most Recent Quarter | 2.46 |
Total Cash Per Share | 5.81 |
Book Value Per Share Most Recent Quarter | 5.07 |
Price to Book Ratio | 14.78 |
Industry Price to Book Ratio | 5.44 |
Sector Price to Book Ratio | 20.88 |
Price to Sales Ratio Twelve Trailing Months | 7.43 |
Industry Price to Sales Ratio Twelve Trailing Months | 13.48 |
Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
Analyst Buy Ratings | 15 |
Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
Total Shares Outstanding | 390,595,000 |
Market Capitalization | 29,247,753,600 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.41% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 15.70% |
Annual Earnings Growth | 58.70% |
Reported EPS 12 Trailing Months | 1.65 |
Reported EPS Past Year | 1.20 |
Reported EPS Prior Year | 1.51 |
Net Income Twelve Trailing Months | 680,800,000 |
Net Income Past Year | 541,500,000 |
Net Income Prior Year | 341,200,000 |
Quarterly Revenue Growth YOY | 2.00% |
5-Year Revenue Growth | 28.03% |
Operating Margin Twelve Trailing Months | 0.15 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 2,271,200,000 |
Total Cash Past Year | 2,726,300,000 |
Total Cash Prior Year | 2,452,300,000 |
Net Cash Position Most Recent Quarter | -168,400,000 |
Net Cash Position Past Year | 292,100,000 |
Long Term Debt Past Year | 2,434,200,000 |
Long Term Debt Prior Year | 1,970,300,000 |
Total Debt Most Recent Quarter | 2,439,600,000 |
Equity to Debt Ratio Past Year | 0.46 |
Equity to Debt Ratio Most Recent Quarter | 0.45 |
Total Stockholder Equity Past Year | 2,068,600,000 |
Total Stockholder Equity Prior Year | 2,131,800,000 |
Total Stockholder Equity Most Recent Quarter | 1,979,000,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 535,000,000 |
Free Cash Flow Per Share Twelve Trailing Months | 1.37 |
Free Cash Flow Past Year | 511,900,000 |
Free Cash Flow Prior Year | 304,700,000 |
Options |
|
Put/Call Ratio | 0.30 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.89 |
MACD Signal | 0.34 |
20-Day Bollinger Lower Band | 49.18 |
20-Day Bollinger Middle Band | 75.06 |
20-Day Bollinger Upper Band | 100.95 |
Beta | 1.17 |
RSI | 63.90 |
50-Day SMA | 105.71 |
150-Day SMA | 104.99 |
200-Day SMA | 107.99 |
System |
|
Modified | 11/20/2024 11:31:55 PM EST |